Seminar - Online
The area of pediatric development is relatively new and changing following the new laws. The use of adult data to support the pediatric initiative allows good adult information to support the children.
This webinar will give you a good taste on what has happened recently. We will discuss the two laws passed : Best Pharmaceuticals for Children Act (BPCA) and Pediatric Research Equity Act (PREA) and review what pharmaceutical companies did in response to these laws. The FDA Safety and Innovation Act of 2012 (FDASIA) will also be described and how it changed the development process. Understanding the FDA approach to pharmaceutical and clinical development in pediatric patients will allow those responsible for planning and implementation of the company to plan effectively. This webinar will benefit formulation development, preclinical, clinical, and regulatory scientists in pharmaceutical companies and clinical research organizations (CRO) that are developing an indication for pediatric patients.
Organization: Compliance Trainings (https://compliancetrainings.com)
For more information, please visit: https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1651
Tuesday, August 11, 2015 (13:00 - 14:00)
Mississauga, Ontario 44813, Canada
Contact: Compliance Trainings (suzzane.d@compliancetrainings.com)
Phone: 4169154458
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
